Device Trial Radar · NCT07909499
BD Onclarity HPV Assay on the BD COR Instrument: Self-collected Vaginal Swabs Validation
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 15, 2026
Primary completion
Dec 15, 2026
Study completion Dec 15, 2026
Sponsor
- Lead sponsor
- Indiana UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 2, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being done to help IU Health validate a new method for HPV testing using self-collected vaginal swab samples. Volunteers will collect two vaginal swabs during a single study visit. The test results from these samples will be compared to results from an already validated collection method to make sure the new testing process performs as expected. The information gathered will be used for laboratory validation and will not be used for medical care or reported back to participants.
Conditions
- Healthy Subjects
- HPV
Interventions
BD Cor OnClarity Self-CollectionDevice
Participants will self-collect two vaginal specimens during a single study visit, including one specimen using the currently validated in-office self-collection method and one specimen using the BD Onclarity At-Home Self-Collection Kit. Both specimens will undergo HPV testing using the BD Onclarity HPV Assay on the BD COR System. Results will be compared to evaluate the performance of at-home self-collected specimens and support laboratory validation prior to clinical implementation.
BD Onclarity HPV AssayDiagnostic test
HPV testing of paired self-collected vaginal specimens using the BD Onclarity HPV Assay on the BD COR System to support laboratory validation of at-home self-collection for HPV screening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Sensitivity of Self-Collected Vaginal Swabs for Detection of High-Risk HPVTime frame: At specimen collection and completion of laboratory testing (up to 30 days)
- Overall Agreement Between Self-Collected Vaginal Swabs and Reference Laboratory HPV ResultsTime frame: At specimen collection and completion of laboratory testing (up to 30 days)
- Clinical Specificity of Self-Collected Vaginal Swabs for Detection of High-Risk HPVTime frame: At specimen collection and completion of laboratory testing (up to 30 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Indiana University, Department of Pathology
Indianapolis, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.